Authors:
ZANCHETTI A
HANSSON L
MENARD J
RAMSAY LE
LARAGH JH
Citation: A. Zanchetti et al., ROUND-TABLE-2 - A CRITIQUE OF THE 5TH JOINT NATIONAL COMMITTEE REPORTIN DETECTION, EVALUATION AND TREATMENT OF HIGH BLOOD-PRESSURE - DISCUSSION, Journal of hypertension, 11, 1993, pp. 190000389-190000394
Citation: Pr. Jackson et al., SELF-MONITORING OF TRIGLYCERIDE CONCENTRATIONS - INAPPROPRIATE ANALYSIS, BMJ. British medical journal, 306(6886), 1993, pp. 1198-1198
Authors:
GHAHRAMANI P
HAQ IU
YEO WW
JACKSON PR
RAMSAY LE
Citation: P. Ghahramani et al., SHEFFIELD CARDIOVASCULAR RISK PROGRAM FOR TARGETING STATIN TREATMENT - SCRIPTS FOR ROUTINE USE IN GENERAL-PRACTICE, Hypertension, 32(4), 1998, pp. 2-2
Citation: Iu. Haq et al., SHEFFIELD RISK AND TREATMENT TABLE FOR CHOLESTEROL-LOWERING FOR PRIMARY PREVENTION OF CORONARY HEART-DISEASE, Lancet, 346(8988), 1995, pp. 1467-1471
Citation: Iu. Haq et al., SHEFFIELD RISK AND TREATMENT TABLE FOR CHOLESTEROL-LOWERING IN PREVENTION OF CORONARY HEART-DISEASE - REPLY, Lancet, 347(8999), 1996, pp. 468-469
Citation: Le. Ramsay et al., SHEFFIELD RISK AND TREATMENT TABLE FOR PRIMARY PREVENTION OF CORONARYHEART-DISEASE - REPLY, Lancet, 348(9033), 1996, pp. 1040-1041
Authors:
RAMSAY LE
HAQ IU
JACKSON PR
YEO WW
PICKIN DM
PAYNE JN
Citation: Le. Ramsay et al., TARGETING LIPID-LOWERING DRUG-THERAPY FOR PRIMARY PREVENTION OF CORONARY-DISEASE - AN UPDATED SHEFFIELD TABLE, Lancet, 348(9024), 1996, pp. 387-388
Citation: Le. Ramsay et al., TARGETING LIPID-LOWERING DRUG-THERAPY FOR PRIMARY PREVENTION OF CORONARY HEART-DISEASE - AN UPDATED SHEFFIELD TABLE (VOL 348, PG 387, 1996), Lancet, 348(9036), 1996, pp. 1251-1252
Citation: Le. Ramsay, THE HYPERTENSION DETECTION AND FOLLOW-UP PROGRAM - 17 YEARS ON, JAMA, the journal of the American Medical Association, 277(2), 1997, pp. 167-170
Authors:
JACKSON PR
HAQ IU
WALLIS EJ
YEO WW
RAMSAY LE
Citation: Pr. Jackson et al., THE IMPACT OF AMBULATORY BLOOD-PRESSURE ON ESTIMATION OF CARDIOVASCULAR RISK IN MILD HYPERTENSION, Journal of hypertension, 16, 1998, pp. 27105-27105
Citation: A. Schelling et al., THE LONG-TERM SAFETY AND EFFICACY OF TELMISARTAN COMPARED TO ATENOLOLIN THE TREATMENT OF HYPERTENSION, Journal of hypertension, 16, 1998, pp. 27096-27096
Citation: I. Ulhaq et al., THE POSSIBLE NEED FOR HMG COA REDUCTASE INHIBITOR TREATMENT IN HYPERTENSIVE PATIENTS FOR PREVENTION OF CORONARY HEART-DISEASE IN THE UK POPULATION, Hypertension, 28(4), 1996, pp. 699-699
Citation: Le. Ramsay et al., THE RATIONALE FOR DIFFERING NATIONAL RECOMMENDATIONS FOR THE TREATMENT OF HYPERTENSION, American journal of hypertension, 11(6), 1998, pp. 79-88
Authors:
WALLIS EJ
RAMSAY LE
YEO WW
JACKSON PR
PICKIN M
HAQ IU
Citation: Ej. Wallis et al., USE OF STATINS - EVIDENCE ON EFFECTIVENESS IS STRONGER FOR STATINS THAN FOR OTHER TREATMENTS, BMJ. British medical journal, 315(7122), 1997, pp. 1618-1619
Authors:
DAVIES SJC
GHAHRAMANI P
PALMER RL
HIPPISLEYCOX J
JACKSON PR
YEO WW
RAMSAY LE
Citation: Sjc. Davies et al., WHITE-COAT EFFECT IN RESISTANT AND NON-RESISTANT HYPERTENSION - A CASE-CONTROL STUDY, Hypertension, 30(4), 1997, pp. 60-60